Jeremy Steele

Jeremy Steele

Jeremy Steele is CEO and Managing Director of Control Bionics.  Control Bionics is a medical device company assisting patients whose ability to communicate verbally or via text and social media is compromised by illnesses such as Motor Neurone Disease (MND)/ Amyotrophic Lateral Sclerosis (ALS), Spinal Cord Injury, Traumatic Brain Injury and Cerebral Palsy among others. Our core patented NeuroNode technology is a wireless wearable device that detects minute signals sent from the brain to any skeletal muscle and is captured as Electromyography (EMG) signals which are processed on personal computers, smartphones and tablets to generate text, text to speech, email and other computer-controlled functions.   

More recently Control Bionics announced the launch of the NeuroStrip which provides comprehensive physiological telemetry: In addition to tracking EMG, EOG, and Spatial data, NeuroStrip extends its capabilities to include Electroencephalography (‘EEG’) and ECG, making it a full-body platform for assistive technology and a versatile tool for many clinical, research and industry applications.  


Jeremy joined Control Bionics in early 2023 and has extensive commercial experience across a number of industries, with the last 12 years in the global healthcare market. 


Share this speaker
  • Organization
    Control Bionics
  • Profession
    CEO and Managing Director
Related sessions

Are you sure you want to remove this speaker?